Adding recombinant AAVs to the cancer therapeutics mix is a research paper published in Molecular Therapy — Oncolytics (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P01HL160472
National Institutes of Health
Grant: R01HL130871
National Institutes of Health
Grant: U54HL142019
National Institutes of Health
Grant: 5U54HL142019-04
Center for the Investigation of Factor VIII Inhibitors and Glycosylation
National Institutes of Health
Grant: 1P01HL160472-01
Toward Safer Gene Therapy for Hemophilia A
National Institutes of Health
Grant: 7R01HL130871-05
Development of highly efficient factor VIII mini-gene therapy
FWCI
1.69
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals